• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状腺毒症后心房颤动的管理

Management of atrial fibrillation in the post-thyrotoxic state.

作者信息

Nakazawa H K, Sakurai K, Hamada N, Momotani N, Ito K

出版信息

Am J Med. 1982 Jun;72(6):903-6. doi: 10.1016/0002-9343(82)90850-6.

DOI:10.1016/0002-9343(82)90850-6
PMID:7091161
Abstract

This study was designed to investigate the appropriate timing for cardioversion in patients with chronic atrial fibrillation who had been rendered euthyroid from a thyrotoxic state. We carried out a retrospective study of 163 patients with thyrotoxic atrial fibrillation, with a mean follow-up of 34 months. With control of thyroid function alone, 101 patients had spontaneous reversion of atrial fibrillation to sinus rhythm and 62 patients had persistent atrial fibrillation. In those with spontaneous reversion, the longest duration of atrial fibrillation prior to the euthyroid state was 13 months. In those with persistent fibrillation, the shortest duration of atrial fibrillation prior to the euthyroid state was eight months. Almost three-quarters of those with spontaneous reversion had conversion to sinus rhythm within three weeks of becoming euthyroid. No spontaneous reversion occurred if atrial fibrillation was still present after the patients had been in a euthyroid state for four months. This study suggests that spontaneous reversion of atrial fibrillation to sinus rhythm is highly unlikely if the duration of atrial fibrillation before the euthyroid state is achieved exceeds 13 months, or if it is still present after the patient has been in a euthyroid state for four months, Cardioversion should be performed at about the 16th week after the euthyroid state is achieved.

摘要

本研究旨在调查甲状腺功能从甲状腺毒症状态恢复正常的慢性心房颤动患者进行心脏复律的合适时机。我们对163例甲状腺毒症性心房颤动患者进行了一项回顾性研究,平均随访34个月。仅通过控制甲状腺功能,101例患者的心房颤动自发恢复为窦性心律,62例患者持续存在心房颤动。在自发恢复的患者中,甲状腺功能正常状态之前心房颤动的最长持续时间为13个月。在持续心房颤动的患者中,甲状腺功能正常状态之前心房颤动的最短持续时间为8个月。几乎四分之三的自发恢复患者在甲状腺功能恢复正常后的三周内恢复为窦性心律。如果患者在甲状腺功能恢复正常状态四个月后仍存在心房颤动,则不会发生自发恢复。本研究表明,如果在达到甲状腺功能正常状态之前心房颤动的持续时间超过13个月,或者在患者处于甲状腺功能正常状态四个月后仍存在心房颤动,则心房颤动自发恢复为窦性心律的可能性极小。应在达到甲状腺功能正常状态后的第16周左右进行心脏复律。

相似文献

1
Management of atrial fibrillation in the post-thyrotoxic state.甲状腺毒症后心房颤动的管理
Am J Med. 1982 Jun;72(6):903-6. doi: 10.1016/0002-9343(82)90850-6.
2
High maintenance rate of sinus rhythm after cardioversion in post-thyrotoxic chronic atrial fibrillation.甲状腺毒症后慢性心房颤动患者心脏复律后窦性心律维持率高。
Int J Cardiol. 1987 Jul;16(1):47-55. doi: 10.1016/0167-5273(87)90269-5.
3
Hyperthyroidism and the management of atrial fibrillation.甲状腺功能亢进症与心房颤动的管理
Thyroid. 2002 Jun;12(6):489-93. doi: 10.1089/105072502760143863.
4
Atrial fibrillation with hyperthyroidism in a 14-year-old male.一名14岁男性患甲状腺功能亢进伴心房颤动。
Pediatr Cardiol. 2006 Nov-Dec;27(6):772-4. doi: 10.1007/s00246-006-1409-x. Epub 2006 Nov 7.
5
[Reversible thyrotoxic cardiomyopathy--report of three cases].[可逆性甲状腺毒症性心肌病——三例报告]
Pol Arch Med Wewn. 2002 Oct;108(4):979-82.
6
Comparison of atrial fibrillation recurrence rates after successful electrical cardioversion in patients with hyperthyroidism-induced versus non-hyperthyroidism-induced persistent atrial fibrillation.甲状腺功能亢进所致持续性心房颤动与非甲状腺功能亢进所致持续性心房颤动患者成功电复律后房颤复发率的比较。
Am J Cardiol. 2009 Feb 15;103(4):540-3. doi: 10.1016/j.amjcard.2008.10.019. Epub 2008 Dec 25.
7
Pharmacologic reversion of persistent atrial fibrillation with amiodarone predicts long-term sinus rhythm maintenance.胺碘酮对持续性心房颤动的药物复律可预测长期窦性心律维持。
J Cardiovasc Pharmacol Ther. 2003 Sep;8(3):179-86. doi: 10.1177/107424840300800302.
8
Oral amiodarone increases the efficacy of direct-current cardioversion in restoration of sinus rhythm in patients with chronic atrial fibrillation.口服胺碘酮可提高直流电复律对慢性心房颤动患者恢复窦性心律的疗效。
Eur Heart J. 2000 Jan;21(1):66-73. doi: 10.1053/euhj.1999.1734.
9
Short-term outcome of early electrical cardioversion for atrial fibrillation in hyperthyroid versus euthyroid patients.甲状腺功能亢进与甲状腺功能正常患者心房颤动早期电复律的短期转归。
Cardiol J. 2012;19(1):53-60. doi: 10.5603/cj.2011.0022.
10
Is there a place for the late cardioversion of atrial fibrillation? A long-term follow-up study of patients with post-thyrotoxic atrial fibrillation.房颤延迟复律是否有意义?一项针对甲状腺毒症后房颤患者的长期随访研究。
Eur Heart J. 2000 Feb;21(4):327-33. doi: 10.1053/euhj.1999.1956.

引用本文的文献

1
Cardiac manifestations in hyperthyroidism.甲状腺功能亢进症的心脏表现。
Rev Cardiovasc Med. 2022 Apr 11;23(4):136. doi: 10.31083/j.rcm2304136. eCollection 2022 Apr.
2
[Arrhythmias in thyroid dysfunction].[甲状腺功能障碍中的心律失常]
Herzschrittmacherther Elektrophysiol. 2024 Sep;35(3):183-192. doi: 10.1007/s00399-024-01030-0. Epub 2024 Jul 18.
3
Epidemiology, prognosis, and challenges in the management of hyperthyroidism-related atrial fibrillation.甲状腺功能亢进相关心房颤动的流行病学、预后及管理挑战。
Eur Thyroid J. 2024 Apr 1;13(2). doi: 10.1530/ETJ-23-0254.
4
2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2023 ACC/AHA/ACCP/HRS 指南:心房颤动的诊断与管理——美国心脏病学会/美国心脏协会联合临床实践指南委员会的报告。
J Am Coll Cardiol. 2024 Jan 2;83(1):109-279. doi: 10.1016/j.jacc.2023.08.017. Epub 2023 Nov 30.
5
2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2023 ACC/AHA/ACCP/HRS 指南:心房颤动的诊断与管理——美国心脏病学会/美国心脏协会联合临床实践指南委员会的报告。
Circulation. 2024 Jan 2;149(1):e1-e156. doi: 10.1161/CIR.0000000000001193. Epub 2023 Nov 30.
6
Atrial fibrillation: primary prevention, secondary prevention, and prevention of thromboembolic complications: part 1.心房颤动:一级预防、二级预防及血栓栓塞并发症的预防:第1部分
Front Cardiovasc Med. 2023 Jun 15;10:1060030. doi: 10.3389/fcvm.2023.1060030. eCollection 2023.
7
Mechanisms and Management of Thyroid Disease and Atrial Fibrillation: Impact of Atrial Electrical Remodeling and Cardiac Fibrosis.甲状腺疾病与心房颤动的机制与管理:心房电重构与心肌纤维化的影响。
Cells. 2022 Dec 14;11(24):4047. doi: 10.3390/cells11244047.
8
Pathogenic Connections in Post-COVID Conditions: What Do We Know in the Large Unknown? A Narrative Review.新冠后状况中的致病关联:在众多未知因素中我们了解到了什么?一篇叙述性综述。
Viruses. 2022 Jul 30;14(8):1686. doi: 10.3390/v14081686.
9
Hyperthyroidism and the Risk of Cardiac Arrhythmias: A Narrative Review.甲状腺功能亢进症与心律失常风险:一篇叙述性综述。
Cureus. 2022 Apr 22;14(4):e24378. doi: 10.7759/cureus.24378. eCollection 2022 Apr.
10
Challenges in the Management of Atrial Fibrillation With Subclinical Hyperthyroidism.伴亚临床甲状腺功能亢进症的心房颤动管理挑战。
Front Endocrinol (Lausanne). 2022 Jan 4;12:795492. doi: 10.3389/fendo.2021.795492. eCollection 2021.